Lysophosphatidic acid: A «bioactive» phospholipid;L'acide lysophosphatidique: Un phospholipide «bioactif»

Medecine/Sciences

Volumn 20, Issue 8-9, 2004, Pages 799-803

  Saulnier Blache, Jean Sébastien ^a  

^a CHU RANGUEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; G PROTEIN COUPLED RECEPTOR; GROWTH FACTOR; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDYLCHOLINE; PHOSPHOLIPASE; PHOSPHOLIPASE A2; PHOSPHOLIPASE D; PHOSPHOLIPID; PROTEIN LPA1; PROTEIN LPA2; PROTEIN LPA3; UNCLASSIFIED DRUG;

ADIPOCYTE; AQUEOUS HUMOR; ASCITES; ATHEROSCLEROSIS; BLOOD; BLOOD VESSEL TONE; CANCER; CANCER CELL; CELL TYPE; DRUG ACTIVITY; ENZYME METABOLISM; EXTRACELLULAR FLUID; HUMAN; HUMAN CELL; IN VIVO STUDY; OBESITY; PATHOPHYSIOLOGY; PHOSPHOLIPID METABOLISM; REPRODUCTION; REVIEW; THROMBOCYTE; TRANSGENE; WOUND HEALING;

EID: 4544247429     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/2004208-9799     Document Type: Review

References (39)

1. Vogt W. Pharmacologically active acidic phospholipids and glycolipids. Biochem Pharmacol 1963; 12: 415-20.
2. Tokumura A, Fukuzawa K, Akamatsu Y, et al. Identification of vasopressor phospholipid in crude soybean lecithin. Lipids 1978; 13: 468-72.
3. Schumacher KA, Classen HG, Spath M. Platelet aggregation evoked in vitro and in vivo by phosphatidic acids and lysoderivatives: Identity with substances in aged serum (DAS). Thromb Haemost 1979; 42: 631-40.
4. Mauco G, Chap H, Simon MF, Douste-Blazy L. Phosphatidic and lysophosphatidic acid production in phospholipase C-and thrombin-treated platelets. Possible involvement of a platelet lipase. Biochimie 1978; 60: 653-61.
5. Van Corven EJ, Groenink A, Jalink K, et al. Lysophosphatidate-induced cell proliferation: Identification and dissection of signaling pathways mediated by G proteins. Cell 1989; 59: 45-54.
6. Hecht JH, Weiner JA, Post SR, Chun J. Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex. J Cell Biol 1996; 135: 1071-83.
7. Aoki J, Taira A, Takanezawa Y, et al. Serum lysophosphatidic acid is produced through diverse phospholipase pathways. J Biol Chem 2002; 277: 48737-44.
8. Westermann A, Havik E, Postma F, et al. Malignant effusions contain lysophosphatidic acid (LPA)-like activity. Ann Oncol 1998; 9: 437-42.
9. Tokumura A, Miyake M, Nishioka Y, et al. Production of lysophosphatidic acids by lysophospholipase D in human follicular fluids of in vitro fertilization patients. Biol Reprod 1999; 61: 195-9.
10. Jaspard B, Collet X, Barbaras R, et al. Biochemical characterization of pre-beta 1 high-density lipoprotein from human ovarian follicular fluid: Evidence for the presence of a lipid core. Biochemistry 1996; 35: 1352-7.
11. Valet P, Pages C, Jeanneton O, et al. Alpha2-adrenergic receptor-mediated release of lysophosphatidic acid by adipocytes. A paracrine signal for preadipocyte growth. J Clin invest 1998; 101: 1431-8.
12. Liliom K, Guan Z, Tseng JL, et al. Growth factor-like phospholipids generated after corneal injury. Am J Physiol 1998; 274: C1065-74.
13. Sugiura T, Nakane S, Kishimoto S, et al. Lysophosphatidic acid, a growth factor-like lipid, in the saliva. J Lipid Res 2002; 43: 2049-55.
14. Capper EA, Marshall LA. Mammalian phospholipases A(2): Mediators of inflammation, proliferation and apoptosis. Prog Lipid Res 2001; 40: 167-97.
15. Fourcade O, Simon MF, Viodé C, et al. Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell 1995; 80: 919-27.
16. Tokumura A, Miyobe M, Yoshimoto O, et al. Metal-ion stimulation and inhibition of lysophospholipase D which generates bioactive lysophosphatidic acid in rat plasma. Lipids 1998; 33: 1009-15.
17. Gesta S, Simon M, Rey A, et al. Secretion of a lysophospholipase D activity by adipocytes: Involvement in lysophosphatidic acid synthesis. J Lipid Res 2002;43:904-10.
18. Tokumura A, Majima E, Kariya Y, et al. Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. J Biol Chem 2002; 277: 39436-42.
19. Ferry G, Tellier E, Try A, et al. Autotaxin is released from adipocytes, catalyses lysophosphatidic acid synthesis, and activates preadipocyte proliferation: Up-regulated expression with adipocyte differentiation and obesity. J Biol Chem 2003; 278: 18162-9.
20. Bollen M, Gijsbers R, Ceulemans H, et al. Nucleotide pyrophosphatasesl phosphodiesterases on the move. Crit Rev Biochem Mol Biol 2000; 35: 393-432.
21. Brindley DN, English D, Pilquil C, et al. Lipid phosphate phosphatases regulate signal transduction through glycerolipids and sphingolipids. Biochim Biophys Acta 2002; 1582: 33-44.
22. Simon MF, Rey A, Castan-Laurel I, et al. Expression of ecto-lipid phosphate phosphohydrolases in 3T3F442A preadipocytes and adipocytes: Involvement in the control of lysophosphatidic acid production. J Biol Chem 2002; 277: 23131-6.
23. Chun J, Goetzl EJ, Hla T, et al. International union of pharmacology. XXXIV. Lysophospholipid receptor nomenclature. Pharmacol Rev 2002; 54: 265-9.
24. Ishii I, Cantos JJ, Fukushima N, Chun J. Functional comparisons of the lysophosphatidic acid receptors, LP(A1)/VZG-1/EDG-2, LP(A2)/EDG-4, and LP(A3)/EDG-7 in neuronal cell lines using a retrovirus expression system. Mol Pharmacol 2000; 58: 895-902.
25. Wu J, Cunnick JM. Trans-regulation of epidermal growth factor receptor by lysophosphatidic acid and G protein-coupled receptors. Biochim Biophys Acta 2002; 1582: 100-6.
26. Cantos JJ, Fukushima N, Weiner JA, et al. Requirement for the IpA1 lysophosphatidic acid receptor gene in normal suckling behavior. Proc Natl Acad Sci USA 2000; 97: 13384-9.
27. Cantos JJ, Ishii I, Fukushima N, et al. Characterization of Ipa(2) (Edg4) and Ipa(1)/Ipa(2)(Edg2/Edg4) lysophosphatidic acid receptor knockout mice: Signaling deficits without obvious phenotypic abnormality attributable to Ipa(2). Mol Cell Biol 2002; 22: 6921-9.
28. Tigyi G, Hong L, Yakubu M, et al. Lysophosphatidic acid alters cerebrovascular reactivity in piglets. Am J Physiol 1995; 268: H2048-55.
29. Karliner JS. Lysophospholipids and the cardiovascular system. Biochim Biophys Acta 2002; 1582: 216-21.
30. Siess W. Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-I-phosphate. Biochim Biophys Acta 2000; 1582: 204-15.
31. Sturm A, Sudermann T, Schulte KM, et al. Modulation of intestinal epithelial wound healing in vitro and in vivo by lysophosphatidic acid. Gastroenterotogy 1999; 117:368-77.
32. Balazs L, Okolicany J, Ferrebee M, et al. Topical application of the phospholipid growth factor lysophosphatidic acid promotes wound healing in vivo. Am J Physiol Regul Integr Comp Physiol 2001; 280: R466-72.
33. 31P magnetic resonance spectroscopy. Int J Colorectal Dis 1991; 6: 121-6.
34. Baker DL, Morrison P, Miller B, et al. Plasma lysophosphatidic acid concentration and ovarian cancer. JAMA 2002; 287: 3081-2.
35. Xu X, Shen Z, Wiper DW, et al. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. JAMA 1998; 280: 719-23.
36. Fang X, Schummer M, Mao M, et al. Lysophosphatidic acid is a bioactive mediator in ovarian cancer. Biochim Biophys Acta. 2002; 1582:257-64.
37. Tokumura A, Kanaya X, Miyake M, et al. Increased production of bioactive lysophosphatidic acid by serum lysophospholipase D in human pregnancy. Biol Reprod 2002; 67: 1386-92.
38. Budnik LT, Mukhopadhyay AK. Lysophosphatidic acid and its role in reproduction. Biol Reprod 2002; 66: 859-65.
39. Pagès C, Daviaud D, An S, et al. Endothelial differentiation gene-2 receptor is involved in lysophosphatidic acid-dependent control of 3T3F442A preadipocyte proliferation and spreading. J Biol Chem 2001; 276:11599-605.